IRIS

Comparison of effectiveness and safety ofinfliximab, etanercept, and adalimumab in psoriatic arthritis patients whoexperienced an inadequate response to previous disease-modifying antirheumaticdrugs / Atteno, Mariangela; Peluso, Rosario; Costa, Luisa; Padula, Stefania; Iervolino, Salvatore; Caso, Francesco; Sanduzzi, A; Lubrano, E; DEL PUENTE, Antonio; Scarpa, Raffaele. - In: CLINICAL RHEUMATOLOGY. - ISSN 0770-3198. - STAMPA. - 29 399-403:4(2010), pp. 399-403.

Comparison of effectiveness and safety ofinfliximab, etanercept, and adalimumab in psoriatic arthritis patients whoexperienced an inadequate response to previous disease-modifying antirheumaticdrugs.

ATTENO, MARIANGELA;PELUSO, ROSARIO;COSTA, LUISA;PADULA, STEFANIA;IERVOLINO, SALVATORE;CASO, FRANCESCO;DEL PUENTE, ANTONIO;SCARPA, RAFFAELE
2010
2010
Comparison of effectiveness and safety ofinfliximab, etanercept, and adalimumab in psoriatic arthritis patients whoexperienced an inadequate response to previous disease-modifying antirheumaticdrugs / Atteno, Mariangela; Peluso, Rosario; Costa, Luisa; Padula, Stefania; Iervolino, Salvatore; Caso, Francesco; Sanduzzi, A; Lubrano, E; DEL PUENTE, Antonio; Scarpa, Raffaele. - In: CLINICAL RHEUMATOLOGY. - ISSN 0770-3198. - STAMPA. - 29 399-403:4(2010), pp. 399-403.
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/372979
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact